CORRESP Filing
Processa Pharmaceuticals, Inc.
Date: June 13, 2025 · CIK: 0001533743 · Accession: 0001641172-25-014985
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287997
Letter
Processa Pharmaceuticals, Inc.
Coca Cola Drive, Suite 106
Hanover, Maryland 21076
June 13, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, NE
Washington, D.C. 20549
Attention: Mr. Chris Edwards
Re: Processa Pharmaceuticals, Inc.
Registration Statement on Form S-1 (Registration No. 333-287997)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, Processa Pharmaceuticals, Inc. (the "Registrant"), hereby requests acceleration of effectiveness of its above-referenced Registration Statement to 5:15 P.M., Eastern time, on June 16, 2025, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Mr. Michael Kirwan of Foley & Lardner LLP of such effectiveness by a telephone call to (904) 633-8913.
Very
truly yours,
Processa
Pharmaceuticals, Inc.
Show Raw Text
CORRESP 1 filename1.htm Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive, Suite 106 Hanover, Maryland 21076 June 13, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, D.C. 20549 Attention: Mr. Chris Edwards Re: Processa Pharmaceuticals, Inc. Registration Statement on Form S-1 (Registration No. 333-287997) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, Processa Pharmaceuticals, Inc. (the "Registrant"), hereby requests acceleration of effectiveness of its above-referenced Registration Statement to 5:15 P.M., Eastern time, on June 16, 2025, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Mr. Michael Kirwan of Foley & Lardner LLP of such effectiveness by a telephone call to (904) 633-8913. Very truly yours, Processa Pharmaceuticals, Inc. By: /s/ George Ng George Ng Chief Executive Officer